Citation only
via Europe PMC
Secretome Derived from Umbilical Cord Mesenchymal Stem Cells as a Therapeutic Approach for Osteoarthritis: Insights from In Vitro, In Vivo, and Clinical Evidence.
Widowati W, Lydia L, Rumayauw J G, Wijaya MP, Caroline S S M, Putera JH, Rachmad MN, Aziz R, Pratama R, Zand E.
Cell biochemistry and biophysics · 2026
Stem-cell exhaustion
Altered intercellular communication
Chronic inflammation
Stem-cell therapy
Cell culture / in vitro
Human
Randomized controlled trial
Preclinical / animal
In vitro
Abstract
Osteoarthritis (OA) is a chronic degenerative joint disorder characterized by articular cartilage deterioration, synovial inflammation, and progressive loss of joint function. Current treatments predominantly address symptoms without modifying structural disease progression, highlighting the need for disease-modifying strategies. Mesenchymal stem cells (MSCs), particularly umbilical cord-derived MSCs (UC-MSCs), exert therapeutic effects primarily through paracrine mechanisms rather than direct engraftment. The UC-MSCs secretome, comprising soluble bioactive factors and extracellular vesicles, modulates pro-inflammatory signaling, inhibits chondrocyte apoptosis, and promotes cartilage matrix biosynthesis. In vitro studies demonstrate restoration of anabolic chondrocyte phenotype, suppression of catabolic enzymes (MMP-13, ADAMTS-5), and attenuation of NF-κB and MAPK pathway activation. Preclinical models show preservation of cartilage architecture, reduced synovial inflammation, and improved joint function following intra-articular administration. Early clinical investigations report reductions in pain scores and functional improvements with favorable short-term safety profiles, though evidence remains largely derived from MSCs-based rather than secretome-specific interventions. Current findings support the biological plausibility and translational potential of UC-MSCs secretome therapy; however, clinical evidence remains limited and heterogeneous. Adequately powered randomized controlled trials with standardized protocols and extended follow-up are required to establish long-term efficacy and safety.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1007/s12013-026-02137-6
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
W, W., L, L., G, R.J., MP, W., M, C.S.S., JH, P., MN, R., R, A., R, P., & E., Z. (2026). Secretome Derived from Umbilical Cord Mesenchymal Stem Cells as a Therapeutic Approach for Osteoarthritis: Insights from In Vitro, In Vivo, and Clinical Evidence. <em>Cell biochemistry and biophysics</em>. https://doi.org/10.1007/s12013-026-02137-6
Vancouver
W W, L L, G RJ, MP W, M CSS, JH P, et al. Secretome Derived from Umbilical Cord Mesenchymal Stem Cells as a Therapeutic Approach for Osteoarthritis: Insights from In Vitro, In Vivo, and Clinical Evidence. Cell biochemistry and biophysics. 2026. doi:10.1007/s12013-026-02137-6.
BibTeX
@article{widowati2026Secret,
title = {Secretome Derived from Umbilical Cord Mesenchymal Stem Cells as a Therapeutic Approach for Osteoarthritis: Insights from In Vitro, In Vivo, and Clinical Evidence.},
author = {Widowati W and Lydia L and Rumayauw J G and Wijaya MP and Caroline S S M and Putera JH and Rachmad MN and Aziz R and Pratama R and Zand E.},
journal = {Cell biochemistry and biophysics},
year = {2026},
doi = {10.1007/s12013-026-02137-6},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cells 2026
Open access · OA
Engineering Mesenchymal Stem Cells for Healthspan-Relevant Applications: Therapeutic Potential, Challenges, and Future Solutions.
GeroScience 2026
Open access · CC-BY
Preserving joint healthspan in knee osteoarthritis: a geroscience-guided review of non-surgical therapies and genicular artery embolization
GeroScience 2026
Open access · OA
Preserving joint healthspan in knee osteoarthritis: a geroscience-guided review of non-surgical therapies and genicular artery embolization.
Current Sports Medicine Reports 2018
Citation only
Mesenchymal Stem Cell Therapy in Osteoarthritis and Regenerative Medicine
Frontiers in Pharmacology 2021
Open access · CC-BY
Aging, Cell Senescence, the Pathogenesis and Targeted Therapies of Osteoarthritis
Aging 2022
Open access · CC-BY